Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
Silverberg JI, Toth D, Bieber T, Alexis AF, Elewski BE, Pink AE, Hijnen D, Jensen TN, Bang B, Olsen CK, Kurbasic A, Weidinger S; ECZTRA 3 study investigators. Silverberg JI, et al. Among authors: olsen ck. Br J Dermatol. 2021 Mar;184(3):450-463. doi: 10.1111/bjd.19573. Epub 2021 Feb 22. Br J Dermatol. 2021. PMID: 33000503 Free PMC article. Clinical Trial.
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials.
Simpson EL, Merola JF, Silverberg JI, Reich K, Warren RB, Staumont-Sallé D, Girolomoni G, Papp K, de Bruin-Weller M, Thyssen JP, Zachariae R, Olsen CK, Wollenberg A. Simpson EL, et al. Among authors: olsen ck. Br J Dermatol. 2022 Dec;187(6):888-899. doi: 10.1111/bjd.21867. Epub 2022 Oct 26. Br J Dermatol. 2022. PMID: 36082590 Free PMC article. Clinical Trial.
Interval Walking Improves Glycemic Control and Body Composition After Cancer Treatment: A Randomized Controlled Trial.
Christensen JF, Sundberg A, Osterkamp J, Thorsen-Streit S, Nielsen AB, Olsen CK, Djurhuus SS, Simonsen C, Schauer T, Ellingsgaard H, Østerlind K, Krarup PM, Mosgaard C, Vistisen K, Tolver A, Pedersen BK, Hojman P. Christensen JF, et al. Among authors: olsen ck. J Clin Endocrinol Metab. 2019 Sep 1;104(9):3701-3712. doi: 10.1210/jc.2019-00590. J Clin Endocrinol Metab. 2019. PMID: 31220283 Clinical Trial.
Corrigendum to ``The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram'' [Journal of Affective Disorders, 227 (2018) 803-809].
Vieta E, Sluth LB, Olsen CK. Vieta E, et al. Among authors: olsen ck. J Affect Disord. 2018 Aug 15;236:319. doi: 10.1016/j.jad.2018.03.011. Epub 2018 Apr 5. J Affect Disord. 2018. PMID: 29807616 No abstract available.
The "Interval Walking in Colorectal Cancer" (I-WALK-CRC) study: Design, methods and recruitment results of a randomized controlled feasibility trial.
Banck-Petersen A, Olsen CK, Djurhuus SS, Herrstedt A, Thorsen-Streit S, Ried-Larsen M, Østerlind K, Osterkamp J, Krarup PM, Vistisen K, Mosgaard CS, Pedersen BK, Højman P, Christensen JF. Banck-Petersen A, et al. Among authors: olsen ck. Contemp Clin Trials Commun. 2018 Feb 6;9:143-150. doi: 10.1016/j.conctc.2018.01.008. eCollection 2018 Mar. Contemp Clin Trials Commun. 2018. PMID: 29696237 Free PMC article.
30 results